Congrats to our COO, Mike Sapieha a newly elected fellow of the Royal Society of Canada. can-acn.org/congratulations-…
SemaThera retweeted
Delighted to share this news of Inversago Pharma! xitter.gq/NewsFromBW/status/1022…
Inversago Pharma Receives $7 Million in Series A Financing dlvr.it/Qcjf3p
SemaThera retweeted
Inversago Pharma Receives $7 Million in Series A Financing dlvr.it/Qcjf3p
SemaThera retweeted
Synthetic #cannabinoid #CB1 receptor blockers poised for a comeback after #Montreal based @inversago pharma announces $7M Series A funding. #T1D #PWS #Lifesciences businesswire.com/news/home/2….
SemaThera retweeted
The Lumira Ventures team is pleased to welcome to Veteran Life Sciences Executive Jason D. Hanson to enGene as the company's new Chief Executive Officer and President #lumiraventures prnewswire.com/news-releases…
SemaThera retweeted
Lumira Ventures portfolio company Antiva Biosciences completes $15 Million Series C-1 financing with Hillhouse Capital, Sirona Capital and existing investors including Canann, Sofinnova, Brace Pharma, Osage and Lumira - markets.businessinsider.com/…
SemaThera retweeted
Annulation de SLAV: un dangereux précédent | Mon billet JDM journaldemontreal.com/2018/0… #SLAV
SemaThera retweeted
"AI-enabled tools will quickly feel invisible, making way for a more personal doctor-to-patient experience. #AI can empower clinicians to do their best work by freeing up their attention to do what only a human can."
Look into the future courtesy... newsroom.gehealthcare.com/be…
SemaThera retweeted
Technology Licensing Officer - Software and IT - Massachusetts Institute of Technology - Cambridge, MA dlvr.it/QXyr1r
SemaThera retweeted
Second session: Study case of SpecificiT Pharma Inc. @PierreBeauparlant CEO of SpecificiT, Grazia Maion from @univalor, Alain Dumont from GGD, Ines Holzbaur @AmorChem
SemaThera retweeted
Thanks to Minister Barrette’s support xitter.gq/cqdm_canada/status/100…
Thanks to Minister Barrette for the announcement of our support to a $1.1M project to develop the main therapeutic antibodies for @iBiosolutions' against cancer #QcBIO2018 #BIO2018
SemaThera retweeted
Veronique Bougie from @corbin_thera doing a great job pitching at the @BIOTECanada dragon’s den!!
SemaThera retweeted
AMORCHEM ANNOUNCES AN INVESTMENT BY FONDACTION IN ITS FUND
businesswire.com/news/home/2…
SemaThera retweeted
SEMA 3A was identified as a novel target for ocular diseasesthat promotes vascular leakage and contributes to diabetes-related macular edema. goo.gl/ZAGBUx #Diabetes #DME @Sema_Thera
SemaThera signed an agreement with Chiome for the exclusivity on the anti-SEMA 3A monoclonal antibody contents.xj-storage.jp/xcont…
SemaThera retweeted
Congrats Mike, and no shock to us, as we have been unraveling macrophage biology and the innate immune system's role in ocular, cardiovascular and respiratory inflammation for some time now, under the umbrellas of our @Mperia_thera and @eosinate_thera newcos! xitter.gq/SciImmunology/status/9…
Macrophages in fat tissue may help promote #healthy weight gain and safeguard against diseases like type 2 #diabetes, find @psapieha & @Umontreal scientists https://xitter.gq/t.co/VXjTAns8xz





















